Dorsey Wright & Associates Scholar Rock Holding Corp Transaction History
Dorsey Wright & Associates
- $376 Million
- Q2 2024
Shares
2 transactions
Others Institutions Holding SRRK
# of Institutions
171Shares Held
75.1MCall Options Held
151KPut Options Held
40.1K-
Artal Group S.A. Luxembourg, N411.3MShares$83.5 Million5.94% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.19MShares$60.8 Million0.01% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA6.79MShares$50.4 Million29.08% of portfolio
-
Black Rock Inc. New York, NY5.66MShares$42 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA5.45MShares$40.5 Million2.96% of portfolio
About Scholar Rock Holding Corp
- Ticker SRRK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,640,600
- Market Cap $383M
- Description
- Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...